Roy Luo Biography and Net Worth

Director of Enfusion

Roy Luo has been a member of Enfusion’s board of directors since 2021 and a member of the board of managers of Enfusion Ltd. LLC since December 2020.

Luo has also served as an investor at ICONIQ Capital since April 2018, and was previously an investor at Technology Crossover Ventures. He holds a bachelor’s degree from Yale University.

How do I contact Roy Luo?: The corporate mailing address for Mr. Luo and other Enfusion executives is , , . Enfusion can also be reached via phone at 312-253-9800 and via email at brian.murphy@icrinc.com. Learn More on Roy Luo's contact information.
Has Roy Luo been buying or selling shares of Enfusion?: Roy Luo has not been actively trading shares of Enfusion during the last ninety days. Most recently, on Monday, October 25th, Roy Luo bought 1,261,594 shares of Enfusion stock. The stock was acquired at an average cost of $17.00 per share, with a total value of $21,447,098.00. Learn More on Roy Luo's trading history.
Who are Enfusion's active insiders?: Enfusion's insider roster includes Bronwen Bastone (Chief People Officer), Matthew Campobasso (General Counsel), Dan Groman (Chief Technology Officer), Bradley Herring (CFO), Roy Luo (Director), Oleg Movchan (CEO), Neal Pawar (Chief Operating Officer), and Deirdre Somers (Director). Learn More on Enfusion's active insiders.
Are insiders buying or selling shares of Enfusion?: During the last twelve months, insiders at the sold shares 29 times. They sold a total of 160,582 shares worth more than $1,648,833.48. The most recent insider tranaction occured on March, 6th when CEO Oleg Movchan sold 11,452 shares worth more than $130,438.28. Insiders at Enfusion own 36.4% of the company. Learn More about insider trades at Enfusion.
Information on this page was last updated on 3/6/2025.

Roy Luo Insider Trading History at Enfusion

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
10/25/2021	Buy	1,261,594	$17.00	$21,447,098.00

Roy Luo Buying and Selling Activity at Enfusion

Enfusion Company Overview

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

Today's Range

Now: $11.16

$11.07

$11.17

50 Day Range

MA: $11.18

$11.01

$11.50

2 Week Range

Now: $11.16

$7.83

$11.80

Volume

400,253 shs

Average Volume

555,547 shs

Market Capitalization

$1.44 billion

P/E Ratio

279.07

Dividend Yield

N/A

Beta

0.95